New findings spark hope for GLP-1 drugs Recent research points to a surprising potential benefit of GLP-1 receptor agonists — the same class that includes weight‑loss medications Ozempic and Wegovy. A growing body of observational data suggests these drugs may be associated with improved cancer survival, particularly in colon cancer. While the results are intriguing,…